Tocilizumab for the Treatment of Familial Mediterranean Fever
NCT03446209
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Familial Mediterranean Fever
Interventions
DRUG:
Tocilizumab Infusion RoAcemtra (EU)
DRUG:
0.9% physiological saline
Sponsor
University Hospital Tuebingen